NMRA

Neumora Therapeutics, Inc.

Biological Products, (No Diagnostic Substances)NasdaqLarge accelerated filer

Total Trades

31

Buys

20

Sells

10

Largest Trade

$1M+

Insiders

11

Institutional Funds

74

Inst. Value

$1M+

Activist Filings

12

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Aurora Daljit SinghSee RemarksSELL$100K–$500K115K$2.68Nov 13, 2025
Burow KristinaDirectorBUY$1M+1.9M$2.61Oct 29, 2025
ARCH Venture Partners XII, LLC10% OwnerBUY$1M+1.9M$2.61Oct 29, 2025
ARCH Venture Partners X, LLC10% OwnerBUY$1M+1.9M$2.61Oct 29, 2025
BERNS PAUL LSee RemarksSELL$15K–$50K14K$1.69Feb 20, 2025
Milligan Michael LeeSee RemarksSELL$1K–$15K2K$1.69Feb 20, 2025
Aurora Daljit SinghChief Strategy Off…SELL$1K–$15K9K$1.68Feb 20, 2025
Lenz Robert A.Head of R&DSELL$1K–$15K6K$1.67Feb 20, 2025
Pinto JoshuaPresidentSELL$1K–$15K8K$1.67Feb 20, 2025
Fust Matthew KDirectorEXERCISE$100K–$500K22K$5.83Oct 18, 2024
Fust Matthew KDirectorSELL$100K–$500K22K$17.03Oct 18, 2024
Lenz Robert A.Head of R&DSELL$100K–$500K14K$15.06Oct 11, 2024
Pinto JoshuaCFOSELL$100K–$500K16K$11.39Aug 27, 2024
Pinto JoshuaCFOSELL$500K+84K$11.67Aug 26, 2024
Burow KristinaDirectorBUY$100K–$500K35K$11.77Nov 15, 2023
ARCH Venture Partners XII, LLC10% OwnerBUY$100K–$500K35K$11.77Nov 15, 2023
Burow KristinaDirectorBUY$1M+141K$10.98Nov 14, 2023
ARCH Venture Partners XII, LLC10% OwnerBUY$1M+141K$10.98Nov 14, 2023
Burow KristinaDirectorBUY$1M+96K$11.49Nov 8, 2023
ARCH Venture Partners XII, LLC10% OwnerBUY$1M+96K$11.49Nov 7, 2023
Burow KristinaDirectorBUY$1M+77K$13.68Sep 29, 2023
ARCH Venture Partners XII, LLC10% OwnerBUY$1M+77K$13.68Sep 29, 2023
Burow KristinaDirectorBUY$500K+59K$11.97Sep 28, 2023
ARCH Venture Partners XII, LLC10% OwnerBUY$500K+59K$11.97Sep 28, 2023
ARCH Venture Partners XII, LLC10% OwnerBUY$1M+101K$11.19Sep 26, 2023
Burow KristinaDirectorBUY$1M+101K$11.19Sep 26, 2023
Burow KristinaDirectorBUY$1M+1.5M$17.00Sep 20, 2023
ARCH Venture Partners X, LLC10% OwnerBUY$1M+1.5M$17.00Sep 20, 2023
ARCH Venture Partners X, LLC10% OwnerBUY$1M+1.5M$17.00Sep 20, 2023
Gosebruch Henry OPresident & CEOBUY$100K–$500K15K$12.62Sep 20, 2023
AMGEN INC10% OwnerBUY$1M+1.8M$17.00Sep 19, 2023
🔓Seeing ranges? Sign in for exact trade values — free forever

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Invus Public Equities, L.P.

SC 13G · Feb 19, 2026

4.9%

8.2M shares

K2 HealthVentures Equity Trust LLC

SC 13G/A · Feb 17, 2026

5.0%

9.0M shares

ARCH Venture Fund VII, L.P.

SC 13D/A · Oct 29, 2025

20.6%

33.8M shares

6.6%

11.4M shares

FMR LLC

SC 13G/A · May 12, 2025

2.2%

3.5M shares

Paul L Berns

SC 13G/A · Feb 13, 2025

5.1%

8.2M shares

SoftBank Group Corp.

SC 13G · Nov 12, 2024

4.7%

7.5M shares

FMR LLC

SC 13G · Jul 8, 2024

5.4%

8.6M shares

FMR LLC

SC 13G · Jul 8, 2024

5.4%

8.6M shares

Paul L Berns

SC 13G · Feb 14, 2024

5.2%

8.0M shares

SoftBank Group Corp.

SC 13G · Feb 13, 2024

5.0%

7.6M shares

Amgen Inc. 2

SC 13D · Sep 27, 2023

23.2%

3.5B shares

View on Google Finance →